Mar 18, 2024 Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Jun 26, 2019 8:55pm EDT Motus GI Announces Pricing of $20 Million Public Offering of Common Stock Read Release
Jun 19, 2019 8:05am EDT Motus GI Bolsters Commercial and Quality/Regulatory Expertise with Two Key Senior Management Additions Read Release
Jun 18, 2019 8:05am EDT Motus GI to Present at the JMP Securities Life Sciences Conference Read Release
May 20, 2019 12:30pm EDT Motus GI Presents Positive Clinical Results from REDUCE Study Evaluating Pure-Vu® System in Hospitalized Colonoscopy Patients at Digestive Disease Week® 2019 Read Release
May 15, 2019 8:35am EDT Motus GI to Present at the 20th Annual B. Riley FBR Investor Conference Read Release
May 10, 2019 8:00am EDT Motus GI Reports First Quarter 2019 Financial Results and Provides Corporate Update Read Release
Apr 29, 2019 8:05am EDT Motus GI to Present Clinical Results from REDUCE Study Evaluating the Pure-Vu® System at Digestive Disease Week® 2019 Read Release